XIMINO SETTLEMENT (Details) - Sun Pharmaceutical Industries, Inc. |
1 Months Ended |
|---|---|
|
Aug. 31, 2024
USD ($)
installment
| |
| XIMINO SETTLEMENT | |
| Milestone payments payable | $ 3,000,000.0 |
| Settlement amount | $ 1,900,000 |
| Number of installments | installment | 3 |
| Gain on settlement | $ 1,100,000 |
| Installment One | |
| XIMINO SETTLEMENT | |
| Settlement amount | 625,000.0 |
| Installment Two | |
| XIMINO SETTLEMENT | |
| Settlement amount | 625,000.0 |
| Installment Three | |
| XIMINO SETTLEMENT | |
| Settlement amount | $ 625,000.0 |
| X | ||||||||||
- Definition Amount of milestone payments to be paid in asset purchase agreement. No definition available.
|
| X | ||||||||||
- Definition Amount of difference between the carrying value of the license installment payments and the settlement amount under the settlement agreement No definition available.
|
| X | ||||||||||
- Definition Amount of settlement obligation under the settlement agreement. No definition available.
|
| X | ||||||||||
- Definition Number of installments, the settlement obligation to be paid off under the agreement. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|